Researchers Victor E. Lubach, PhD, and Irving Kron, MD, received the grants to support projects and research that may increase the number of lungs available for transplant, create a way to detect post-transplant complications, prevent lung rejection and hinder lung ischemia reperfusion injuries, which occur when oxygen supply to the lung is compromised.
“We envision UVA as eventually becoming a lung rehab center where donor lungs would arrive to undergo [ex vivo lung perfusion] and, if they look great, they can be sent out to the appropriate hospital for transplant,” Dr. Laubach, who is collaborating on the project with Dr. Kron, a UVA transplant surgeon, told NewsMedical.net.
EVLP is the process of assessing and preparing donor lungs outside of a body prior to transplant surgery.
More articles on healthcare finance:
CMS releases Open Payments data for 2016: 5 things to know
10 recent donations, grants to healthcare organizations
56 hospital, health system outlook and credit rating actions in June
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
